Apr 13 2017

A potential for earlier…


There are two main physical hallmarks visible in the brain of Alzheimer patients: plaques of beta-amyloid protein aggregates and intracellular hyperphosphorlyates neurofibrillary tangles of the tau protein. Their detection plays an  important role in the diagnosis of Alzeimer’s, but only occurs through costly and time-consuming methods at a late stage of the disease’s development. The early identification of the beta-amyloid protein in the eyes could become a general screening method for aging individuals.


Source : T.M. Shah, S.M. Gupta, P. Chatterjee, M. Campbell and R.N. Martins «Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer’s disease», Molecular Psychiatry 22, March 2017

See the article here